Skip to main content
. 2019 Aug 30;16(17):3171. doi: 10.3390/ijerph16173171

Table 2.

Pre-operative, patient-level factors that predict diabetes remission following bariatric surgery, identified among different studies.

Study Factors Predicting Remission Factors Exerting a Neutral Effect
Pories et al. (1995) [42]
  • Shorter T2DM duration

  • Younger age

Dixon et al. (2002) [44]
  • Shorter diabetes duration

Schauer et al. (2003) [46]
  • Better pre-operative glycemic control

  • Absence of insulin treatment

  • Shorter diabetes duration

Dixon et al. (2008) [48]
  • Better pre-operative glycemic control

  • Sex, age, baseline BMI, baseline C-peptide level, time spent engaged in planned physical activity

Schauer et al. (2012) (STAMPEDE) [51]
  • Shorter T2DM duration

  • Age, sex, insulin use pre-op, baseline BMI, HbA1c, C-peptide, CRP, BP, lipids

Mingrone et al. (2012) [52]
  • Baseline triglyceride concentration

Carlsson et al. (2012) (SOS cohort) [53]
  • Shorter T2DM duration, use of oral antidiabetic agents vs. no use, lower baseline glucose

  • Age, sex, baseline BMI, baseline insulin treatment

Gregg et al. (2012) (Look AHEAD) [55]
  • Shorter diabetes duration

  • Better pre-operative glycemic control

  • Absence of insulin treatment

  • Age, sex, race, baseline BMI, antihypertensive treatment, history of cardiovascular disease (CVD)

Arteburn et al. (2013) [56]
  • Male sex

  • Shorter T2DM duration

  • Better pre-operative glycemic control

  • No use of oral antidiabetic agents or insulin treatment on baseline

  • Age

Arteburn et al. (2013) [58]
  • Younger age

  • Shorter T2DM duration

  • No use of oral antidiabetic agents or insulin treatment on baseline

  • Better pre-operative glycemic control

  • Higher baseline BMI

  • Sex

Cummings et al. (2016) (CROSSROADS) [64]
  • Age, sex, baseline BMI, diabetes duration, insulin usage

Purnell et al. (2016) (LABS-2) [65]
  • Shorter diabetes duration

  • Better pre-operative glycemic control

  • No insulin treatment (AGB > RYGB)

  • Baseline weight (AGB)

  • Preserved insulin secretory function (RYGB)

  • Baseline BMI (RYGB)

  • Preserved insulin secretory function (AGB)

Madesin et al. (2019) [67]
  • Younger age

  • Shorter diabetes duration

  • Better pre-operative glycemic control

  • No use of oral antidiabetic agents or insulin treatment on baseline

  • Sex

  • Charlson comorbidity index

  • History of depression or other psychiatric disorders

BMI: body mass index; T2DM: diabetes mellitus type 2; AGB: adjustable gastric banding; RYGB: Roux-en-Y gastric bypass.